{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:01:21Z","timestamp":1767211281964},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01171-5","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:02:08Z","timestamp":1693504928000},"page":"4123-4128","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is there a correlation between antibiotic use and the severity or post-infection conditions of COVID-19 and other viral infections?"],"prefix":"10.1007","volume":"23","author":[{"given":"Tsz Yuen","family":"Au","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanika","family":"Assavarittirong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamiram","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskar Wojciech","family":"Wi\u015bniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40545-022-00404-4","volume":"15","author":"I-N Mohamad","year":"2022","unstructured":"Mohamad I-N, Wong CK-W, Chew C-C, et al. The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective. J Pharm Policy Pract. 2022;15:4.","journal-title":"J Pharm Policy Pract"},{"key":"1171_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-021-00083-w","volume":"13","author":"C Feldman","year":"2021","unstructured":"Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia. 2021;13:5.","journal-title":"Pneumonia"},{"key":"1171_CR3","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","volume":"72","author":"VM Vaughn","year":"2021","unstructured":"Vaughn VM, Gandhi TN, Petty LA, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis. 2021;72:e533\u201341.","journal-title":"Clin Infect Dis"},{"key":"1171_CR4","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1186\/s12879-021-06821-1","volume":"21","author":"AD Bendala Estrada","year":"2021","unstructured":"Bendala Estrada AD, Calder\u00f3n Parra J, Fern\u00e1ndez Carracedo E, et al. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy. BMC Infect Dis. 2021;21:1144.","journal-title":"BMC Infect Dis"},{"key":"1171_CR5","doi-asserted-by":"publisher","first-page":"e0272375","DOI":"10.1371\/journal.pone.0272375","volume":"17","author":"FS Alshaikh","year":"2022","unstructured":"Alshaikh FS, Godman B, Sindi ON, Seaton RA, Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis. PLoS ONE. 2022;17:e0272375.","journal-title":"PLoS ONE"},{"key":"1171_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","volume":"27","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27:520\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"1171_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492\u2013506.","journal-title":"Cell Res"},{"key":"1171_CR8","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/antibiotics10111364","volume":"10","author":"C Llor","year":"2021","unstructured":"Llor C, Ouchi D, Giner-Soriano M, Garc\u00eda-Sangen\u00eds A, Bjerrum L, Morros R. Correlation between previous antibiotic exposure and COVID-19 severity. A population-based cohort study. Antibiotics. 2021;10:1364.","journal-title":"Antibiotics"},{"key":"1171_CR9","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1016\/j.celrep.2018.03.001","volume":"22","author":"LB Thackray","year":"2018","unstructured":"Thackray LB, Handley SA, Gorman MJ, et al. Oral antibiotic treatment of mice exacerbates the disease severity of multiple flavivirus infections. Cell Rep. 2018;22:3440-3453.e6.","journal-title":"Cell Rep"},{"key":"1171_CR10","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1073\/pnas.1019378108","volume":"108","author":"T Ichinohe","year":"2011","unstructured":"Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A. 2011;108:5354\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1171_CR11","first-page":"304","volume":"11","author":"M Papatriantafyllou","year":"2011","unstructured":"Papatriantafyllou M. Flora against the flu. Nat Rev Immunol. 2011;11:304\u20135.","journal-title":"Nat Rev Immunol"},{"key":"1171_CR12","first-page":"651","volume":"66","author":"S Mohsen","year":"2020","unstructured":"Mohsen S, Dickinson JA, Somayaji R. Update on the adverse effects of antimicrobial therapies in community practice. Can Fam Physician. 2020;66:651\u20139.","journal-title":"Can Fam Physician"},{"key":"1171_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/01.NPR.0000794520.66134.e4","volume":"46","author":"S Waterbury","year":"2021","unstructured":"Waterbury S. Post-COVID conditions\u2014what practitioners need to know. Nurse Pract. 2021;46:44.","journal-title":"Nurse Pract"},{"key":"1171_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jgar.2020.06.016","volume":"22","author":"LG Parra-Lara","year":"2020","unstructured":"Parra-Lara LG, Mart\u00ednez-Arboleda JJ, Rosso F. Azithromycin and SARS-CoV-2 infection: where we are now and where we are going. J Glob Antimicrob Resist. 2020;22:680\u20134.","journal-title":"J Glob Antimicrob Resist"},{"key":"1171_CR15","doi-asserted-by":"publisher","first-page":"106053","DOI":"10.1016\/j.ijantimicag.2020.106053","volume":"56","author":"A Pani","year":"2020","unstructured":"Pani A, Lauriola M, Romandini A, Scaglione F. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. Int J Antimicrob Agents. 2020;56:106053.","journal-title":"Int J Antimicrob Agents"},{"key":"1171_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s10930-020-09935-8","volume":"39","author":"S Suhail","year":"2020","unstructured":"Suhail S, Zajac J, Fossum C, et al. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. Protein J. 2020;39:644\u201356.","journal-title":"Protein J"},{"key":"1171_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2020.11.001","volume":"54","author":"L Almeida","year":"2021","unstructured":"Almeida L, Dhillon-LaBrooy A, Castro CN, et al. Ribosome-targeting antibiotics impair T cell effector function and ameliorate autoimmunity by blocking mitochondrial protein synthesis. Immunity. 2021;54:68-83.e6.","journal-title":"Immunity"},{"key":"1171_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.tim.2022.01.007","volume":"30","author":"NI Wirusanti","year":"2022","unstructured":"Wirusanti NI, Baldridge MT, Harris VC. Microbiota regulation of viral infections through interferon signaling. Trends Microbiol. 2022;30:778\u201392.","journal-title":"Trends Microbiol"},{"key":"1171_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2022.04.006","volume":"55","author":"SF Erttmann","year":"2022","unstructured":"Erttmann SF, Swacha P, Aung KM, et al. The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immunity. 2022;55:847-861.e10.","journal-title":"Immunity"},{"key":"1171_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2143476","author":"V Rossini","year":"2022","unstructured":"Rossini V, Tolosa-Enguis V, Frances-Cuesta C, Sanz Y. Gut microbiome and anti-viral immunity in COVID-19. Crit Rev Food Sci Nutr. 2022. https:\/\/doi.org\/10.1080\/10408398.2022.2143476.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1171_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1136\/gutjnl-2021-324622","volume":"70","author":"MF Neurath","year":"2021","unstructured":"Neurath MF, \u00dcberla K, Ng SC. Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut. 2021;70:1605\u20138.","journal-title":"Gut"},{"key":"1171_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.12688\/f1000research.52540.1","volume":"10","author":"M Petrillo","year":"2021","unstructured":"Petrillo M, Brogna C, Cristoni S, Querci M, Piazza O, Van den Eede G. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology. F1000Res. 2021;10:370.","journal-title":"F1000Res"},{"key":"1171_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00284-013-0380-z","volume":"67","author":"S Wu","year":"2013","unstructured":"Wu S, Jiang Z-Y, Sun Y-F, et al. Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection. Curr Microbiol. 2013;67:414\u201322.","journal-title":"Curr Microbiol"},{"key":"1171_CR24","doi-asserted-by":"publisher","first-page":"106462","DOI":"10.1016\/j.ijantimicag.2021.106462","volume":"59","author":"X Yin","year":"2022","unstructured":"Yin X, Xu X, Li H, et al. Evaluation of early antibiotic use in patients with non-severe COVID-19 without bacterial infection. Int J Antimicrob Agents. 2022;59:106462.","journal-title":"Int J Antimicrob Agents"},{"key":"1171_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40264-020-00976-7","volume":"43","author":"J Sultana","year":"2020","unstructured":"Sultana J, Cutroneo PM, Crisafulli S, Puglisi G, Caramori G, Trifir\u00f2 G. Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines. Drug Saf. 2020;43:691\u20138.","journal-title":"Drug Saf"},{"key":"1171_CR26","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.3390\/cells11162572","volume":"11","author":"PB Rodrigues","year":"2022","unstructured":"Rodrigues PB, Gomes GF, Angelim MKSC, et al. Impact of microbiota depletion by antibiotics on SARS-CoV-2 infection of K18-hACE2 mice. Cells. 2022;11:2572.","journal-title":"Cells"},{"key":"1171_CR27","doi-asserted-by":"publisher","first-page":"103403","DOI":"10.1016\/j.ebiom.2021.103403","volume":"68","author":"R Abdelnabi","year":"2021","unstructured":"Abdelnabi R, Boudewijns R, Foo CS, et al. Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters. eBioMedicine. 2021;68:103403.","journal-title":"eBioMedicine"},{"key":"1171_CR28","doi-asserted-by":"publisher","first-page":"00964-21","DOI":"10.1128\/JVI.00964-21","volume":"96","author":"W Dong","year":"2022","unstructured":"Dong W, Mead H, Tian L, et al. The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus. J Virol. 2022;96:00964\u201321.","journal-title":"J Virol"},{"key":"1171_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3389\/fcimb.2018.00319","volume":"8","author":"E Fuglsang","year":"2018","unstructured":"Fuglsang E, Pizzolla A, Krych L, et al. Changes in gut microbiota prior to influenza A Virus infection do not affect immune responses in pups or juvenile mice. Front Cell Infect Microbiol. 2018;8:319.","journal-title":"Front Cell Infect Microbiol"},{"key":"1171_CR30","doi-asserted-by":"publisher","first-page":"e01873","DOI":"10.1128\/jvi.01873-21","volume":"96","author":"E-H Kim","year":"2022","unstructured":"Kim E-H, Nguyen T-Q, Casel MAB, et al. Coinfection with SARS-CoV-2 and influenza A virus increases disease severity and impairs neutralizing antibody and CD4+ T cell responses. J Virol. 2022;96:e01873-e1921.","journal-title":"J Virol"},{"key":"1171_CR31","doi-asserted-by":"publisher","first-page":"pgac071","DOI":"10.1093\/pnasnexus\/pgac071","volume":"1","author":"C Pawlowski","year":"2022","unstructured":"Pawlowski C, Silvert E, O\u2019Horo JC, et al. SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes. PNAS Nexus. 2022;1:pgac071.","journal-title":"PNAS Nexus"},{"key":"1171_CR32","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1001\/jama.2020.6266","volume":"323","author":"D Kim","year":"2020","unstructured":"Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085\u20136.","journal-title":"JAMA"},{"key":"1171_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12985-021-01594-0","volume":"18","author":"B Alosaimi","year":"2021","unstructured":"Alosaimi B, Naeem A, Hamed ME, et al. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J. 2021;18:127.","journal-title":"Virol J"},{"key":"1171_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2023.04.013","volume":"137","author":"I Gajic","year":"2023","unstructured":"Gajic I, Jovicevic M, Popadic V, et al. The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study. J Hosp Infect. 2023;137:1\u20137.","journal-title":"J Hosp Infect"},{"key":"1171_CR35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/ijerph18031003","volume":"18","author":"E Bentivegna","year":"2021","unstructured":"Bentivegna E, Luciani M, Arcari L, Santino I, Simmaco M, Martelletti P. Reduction of multidrug-resistant (MDR) bacterial infections during the COVID-19 pandemic: a retrospective study. Int J Environ Res Public Health. 2021;18:1003.","journal-title":"Int J Environ Res Public Health"},{"key":"1171_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ajic.2020.09.010","volume":"49","author":"E Bentivegna","year":"2021","unstructured":"Bentivegna E, Alessio G, Spuntarelli V, et al. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection. Am J Infect Control. 2021;49:640\u20132.","journal-title":"Am J Infect Control"},{"key":"1171_CR37","unstructured":"Au TY, Assavarittirong C. Combating antimicrobial resistance: a review of bacteriophage therapy in clinical setting. In: Beyond sciences. Beyond Sciences Initiative, 2021."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01171-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T16:12:50Z","timestamp":1702743170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01171-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01171-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}